UltimaEdizione.Eu  > 

Usa: news studies corroborates italian research. Thiamine fights Parkinson’s disease

Usa: news studies corroborates italian research. Thiamine fights Parkinson’s disease

A research has confirmed the results obtained in Italy by Professor Antonio Costantini regarding the use of Thiamine to fight Parkinson’s disease. The National Center for Biotechnology Information of the United States have published the study on their website. The program followed 50 patients which have been treated since June 2012.

Ultima Edizione has dedicated a section to Costantini’s studies on Parkinson’s.

The research concerned 33 men and 17 women aged between 70 and 13 years old, which have suffered from this disease for an average of 7.3 and 6.7 years. All of the patients began their treatment with an intramuscular injection of 100mg of Thiamine twice a week, without any personal variation. Every patient was reevaluated after a month and underwent controls every three months during the treatment.

According to the researchers, treating patients with Thiamine has led to a significant improvement in the motor and non motor symptoms within three months and has remained stable after time. Some patients of a condition of medium to bad severity have seen a complete regression of the symptoms. The period of observation varied between 95 and 831 days, with an average length of 291 and 207 days.

The conclusions drawn by the Italian researchers, among which doctor Roberto Fancellu, are that the parenteral administration of high doses of Thiamine has proven effective in countering Parkinson’s motor and non motor symptoms. Every patient’s improvement has remained stable throughout time.

“From our clinical evidence, written in the research, we hypothesize that a dysfunction in the thiamine-dependant metabolic processes could cause selective neuronal damage in areas commonly affected by this illness and could be a fundamental molecular event causing neurodegeneration. Thiamine could have a restorative and protective effect against Parkinson’s disease”.